2:04

Critical Content: Critical Care Medicine, August 2024

August 05, 2024

Aarti Sarwal, MD, FAAN, FNCS, FCCM, shares highlights from the August 2024 issue of Critical Care Medicine.


Video Transcript


Speaker: Aarti Sarwal, MD, FAAN, FNCS, FCCM

Aarti Sarwal, MD, FAAN, FNCS, FCCM: Hello, I'm Aarti Sarwal, the Social Media Editor of Critical Care Medicine. Here are my top reads from the August issue of CCM. An article by Henríquez-Beltrán and colleagues describes the sleep and circadian rhythm in survivors of critical illness. The investigators followed 260 ARDS patients for 12 months after ICU discharge to evaluate their quality of sleep. The editorial by Matthew Maas discusses the long term effects of unnatural sleep and ties in the old adage, a good laugh and good sleep are the best cures in the doctor's book. Check it out. Another article by Emily See and colleagues report on a prespecified analysis of ARAMIS trial - Acute Renal effect of Angiotensin II management in Shock. They investigated 40 critically ill adults who received angiotensin 2 as the primary vasopressor. They looked at exposure to recent RAS inhibitors and reported on Brennan levels before and after pressor initiation in these patients. The study suggests the potential role of renin as a biomarker in selecting and monitoring patients in future angiotensin 2 trials. But it also emphasizes the importance of studying RAS pathophysiology in vasopressor-dependent vasodilatory hypotension. Third, don't miss the guidelines on prevention of stress related GI bleeding in critically ill adults put forth by SCCM and the American Society of Health System Pharmacists. Lastly, the article by Sara Nikravan and colleagues describes the intentional and transparent approach taken by the critical care ultrasound guidelines to diversifying the selection of a guideline panel. A road map to inclusivity for future efforts. For more articles, please follow us on Facebook and X. Stay cool this summer. Goodbye.



Produced with Vocal Video